Extended Follow-up of Microbiome Therapeutic SER-109 for Recurrent Clostridioides difficile Infection-Reply - PubMed (original) (raw)

Comment

. 2023 Mar 28;329(12):1033-1034.

doi: 10.1001/jama.2023.0496.

Affiliations

• PMID: 36976280
• DOI: 10.1001/jama.2023.0496

Comment

Extended Follow-up of Microbiome Therapeutic SER-109 for Recurrent Clostridioides difficile Infection-Reply

Stuart H Cohen et al. JAMA. 2023.

No abstract available

PubMed Disclaimer

Comment on

• Extended Follow-up of Microbiome Therapeutic SER-109 for Recurrent Clostridioides difficile Infection.
  Hamilton F, Wright WF, Lee TC. Hamilton F, et al. JAMA. 2023 Mar 28;329(12):1032-1033. doi: 10.1001/jama.2023.0497. JAMA. 2023. PMID: 36976283 No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems